Expertise in
8
conditions

Hui M. Ren

No. 71 Xinmin Street, 
Changchun, CN 
Expertise in
8
conditions
No. 71 Xinmin Street, 
Changchun, CN 

Overview

Hui Ren practices practicing medicine in Changchun, China.

Ms. Ren is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Osteoporosis, Cervical Spondylosis, Lung Cancer, Oophorectomy, and Spinal Fusion.

She is actively involved in clinical research, co-authoring 546 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

No. 71 Xinmin Street, Changchun, 130021, China
Other Locations
No. 71 Xinmin Street, Changchun, China
Key Laboratory Of Carcinogenesis And Translational Research, Beijing, China
No. 277, Yanta West Road, Xi'an, 710061, China
277 Yanta West Road, Xi'an, China
No. 2 Tiansheng Road, Beibei, 400716, China
Dong Gang Xi Road 199#, Lanzhou, 730000, China
No.1163 Xinmin Street, Changchun, 130021, China
16 Airport Road, Guangzhou, 510405, China
58 Zhongshan 2nd Road, Guangzhou, 510080, China
NO. 1163 Xinmin Street, Changchun, China
No. 79 West Yingze Street, Taiyuan, 030024, China
No. 199, Donggang West Road, Lanzhou, 730000, China
NO. 1095 Jiefang Avenue, Wuhan, 430030, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Single Center, Controlled Phase II Study to Compare Laparoscopic Versus Open Distal Gastrectomy in Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
A Randomized, Single Center, Controlled Phase II Study to Compare Laparoscopic Versus Open Distal Gastrectomy in Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
Enrollment Status: Unknown
Publish Date: September 28, 2018
Intervention Type: Procedure, Drug
Study Drugs: Neoadjuvant Chemotherapy, Adjuvant Chemotherapy
Study Phase: Phase 2

546 Total Publications

Dendritic cell and/or PD-1 monoclonal antibody therapy induces intratumoral remodeling of CD8⁺T cells in humanized cerebral glioblastoma mice models
Dendritic cell and/or PD-1 monoclonal antibody therapy induces intratumoral remodeling of CD8⁺T cells in humanized cerebral glioblastoma mice models
Journal: Zhonghua yi xue za zhi
Published: July 06, 2026

Frequently Asked Questions about Hui M. Ren

Is Hui M. Ren a top-rated expert for Osteoporosis?

MediFind is an objective health platform that identifies experts based on real-world data. Hui M. Ren is classified as an Distinguished expert for Osteoporosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hui M. Ren participate in research or clinical trials?

Yes. Hui M. Ren has published 546 articles and abstracts on conditions like Osteoporosis. You can view a list of Hui M. Ren's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Ren's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 83 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile